Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00257_DB01222_nanopub.RA4LTRDrIfPylpivLEFxPrrlv6ucb_gKmGUo9vTaB3zjs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00257_DB01222 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00257_DB01222 label "DDI between Clotrimazole and Budesonide - CYP3A4 Inhibitors (Moderate) such as clotrimazole may increase the serum concentration of Budesonide (Systemic, Oral Inhalation). Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor. This interaction is likely less severe with orally inhaled budesonide. Any patient receiving both budesonide and a moderate CYP3A4 inhibitor should be monitored closely for signs/symptoms of corticosteroid excess. [drugbank_resource:DB00257_DB01222]" assertion.
- drugbank_resource:DB00257_DB01222 identifier "drugbank_resource:DB00257_DB01222" assertion.
- drugbank_resource:DB00257_DB01222 title "DDI between Clotrimazole and Budesonide - CYP3A4 Inhibitors (Moderate) such as clotrimazole may increase the serum concentration of Budesonide (Systemic, Oral Inhalation). Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor. This interaction is likely less severe with orally inhaled budesonide. Any patient receiving both budesonide and a moderate CYP3A4 inhibitor should be monitored closely for signs/symptoms of corticosteroid excess." assertion.
- drugbank:DB01222 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00257_DB01222 assertion.
- drugbank:DB00257 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00257_DB01222 assertion.